West Virginia University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, West Virginia University sits in the top decile of US sponsors by registered trial count (#216 of 15,742 sponsors by registered trial count).

122 total trials 22 currently recruiting 73 completed early-phase tilt top decile by trial count

West Virginia University: 122 sponsored US clinical trials, 22 recruiting.

West Virginia University sponsors 122 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 73 completed. 12 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Driving Performance, with 2 trials.

Top-decile sponsor footprint

West Virginia University ranks in the top decile of sponsors by registered trial count (#216 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 47/100

73 of 88 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

122 total, page 1 of 3

RECRUITING

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

NCT07625189

RECRUITING Phase 1

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

NCT07401277

RECRUITING Phase 2

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

NCT07222579

RECRUITING NA

Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

NCT06960720

RECRUITING NA

Remote Vinyasa Yoga Program for Heart Health

NCT06961981

RECRUITING Phase 1

Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes

NCT06923488

RECRUITING Phase 1

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

NCT06686914

RECRUITING NA

Sustaining Home Heart Failure Palliative Care in Rural Appalachia

NCT06791850

RECRUITING Phase 1

Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride

NCT06820164

RECRUITING NA

NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics

NCT06808503

RECRUITING NA

rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

NCT06237868

RECRUITING NA

rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings

NCT06228235

RECRUITING NA

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

NCT05705999

RECRUITING Phase 2

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

NCT05537896

RECRUITING

Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

NCT05507151

RECRUITING

Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

NCT05535894

RECRUITING Early Phase 1

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

NCT05430035

RECRUITING Phase 2

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

NCT05013255

RECRUITING NA

Effects of Blocking Blue Light At Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH

NCT04578249

RECRUITING Phase 1

Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

NCT04911816

RECRUITING Phase 3

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

NCT04376034

RECRUITING

Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity

NCT02879630

ACTIVE NOT RECRUITING NA

Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs

NCT05976672

ACTIVE NOT RECRUITING Phase 1

Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma

NCT04922723

ACTIVE NOT RECRUITING NA

Influence of SRP With MM on the Composition and Functional Characteristics of Subgingival Microbiome Communities

NCT05422742

ACTIVE NOT RECRUITING Phase 1

2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML

NCT04953780

ACTIVE NOT RECRUITING NA

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

NCT03950492

NOT YET RECRUITING NA

Tailored MgSO4 Supplementation to Reduce Complications in Pediatric Heart Surgery

NCT06564376

NOT YET RECRUITING NA

Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity

NCT07674979

NOT YET RECRUITING NA

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C

NCT07662083

NOT YET RECRUITING NA

Xpan Non-Inferiority Study

NCT07385690

NOT YET RECRUITING

Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic

NCT07317687

NOT YET RECRUITING Phase 3

Orthodontic Pain Alleviation With Chewing Gum

NCT07210697

NOT YET RECRUITING NA

Preventing Perinatal Anxiety: Testing an Internet-delivered Intervention

NCT07071025

COMPLETED NA

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)

NCT06612788

TERMINATED Phase 4

Comparing Oral Versus Parenteral Antimicrobial Therapy

NCT05977868

COMPLETED NA

PBM or Dry Float Therapy on Sleep Quality in Middle-aged and Elderly

NCT05963555

COMPLETED NA

Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

NCT05903495

COMPLETED NA

Using Aromatherapy in Substance Use Disorder

NCT05660434

TERMINATED Phase 4

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)

NCT05156437

COMPLETED NA

Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain

NCT05260918

COMPLETED NA

Examining the Differential Effects of Traditional Float-REST on Sleep and Recovery

NCT05154032

COMPLETED NA

Examining the Differential Effects of Photobiomodulation on Sleep and Performance

NCT05116605

COMPLETED NA

Efficacy of Commercially Available Technology in Augmenting Sleep and Well-being

NCT05118191

COMPLETED Phase 4

Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections

NCT04900220

COMPLETED NA

Sleep Well Live Well (SWELL) Pilot Project

NCT04849572

COMPLETED NA

Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement

NCT05082948

COMPLETED NA

Discontinuing CRRT in Patients with Acute Kidney Injury

NCT04898595

COMPLETED Phase 2

The Effects of Cannabidiol on the Driving Ability of Healthy Adults

NCT04590495

COMPLETED NA

Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.

NCT04762706

Page 1 of 3 Next →

What is open in the West Virginia University pipeline

22 recruiting of 122 indexed (18% open); 73 completed (60%).

Phase mix: 12 late (III/IV) vs 22 early (I/II) (early-phase heavy).

Top condition: Driving Performance (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

West Virginia University: open-pipeline peers nationwide

Peers matched on 122 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

West Virginia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 10%15%20%25%30%35% Total trials Recruiting share West Virginia UniversityMichigan State UniversityMethodist Health SystemChildren's Hospital Los AngelesJaeb Center for Health ResearchHospital for Special Surgery, New YorkGeorge Washington UniversityUniversity of California, BerkeleyChildren's Hospital of Philadelphia
West Virginia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

West Virginia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 122 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this West Virginia University page

122 registered trials is a research-attention snapshot, not an endorsement of West Virginia University or any single study.

  • 22 of West Virginia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Driving Performance is the condition West Virginia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Driving Performance trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

West Virginia University pipeline card: 122 registered trials from official public datasets.Report a data error.